Project Oncology®

187 Folgen

1. B-Cell Lymphoma Care: Overcoming Challenges in the Second-Line Setting

   Vom: 4.4.2024
2. Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care

   Vom: 4.4.2024
3. Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights

   Vom: 13.3.2024
4. mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib

   Vom: 20.2.2024
5. Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access

   Vom: 15.2.2024
6. Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification

   Vom: 9.2.2024
7. Novel Immune Checkpoint Strategies in Non-Small Cell Lung Cancer Care

   Vom: 9.2.2024
8. Emerging Strategies in Multi-Cancer Early Detection

   Vom: 29.1.2024
9. The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey

   Vom: 29.1.2024
10. Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU

    Vom: 25.1.2024
11. ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer

    Vom: 25.1.2024
12. Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans

    Vom: 25.1.2024
13. Treating Patients with NSCLC: Decision-Making and Surgical Considerations

    Vom: 8.1.2024
14. NSCLC Care: Evaluating Durvalumab in the First-Line Setting

    Vom: 28.12.2023
15. How Do We Implement ANNEXXa-I Into Our Clinical Practice?

    Vom: 22.12.2023
16. SABCS 2023: A Look into New Research for Inflammatory Breast Cancer

    Vom: 21.12.2023
17. Inflammatory Breast Cancer: A New Scoring System Proposed

    Vom: 21.12.2023
18. A Look at What’s New in Invasive Lobular Carcinoma

    Vom: 8.12.2023
19. When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies

    Vom: 6.11.2023
20. Examining the Economic Impacts of Biosimilars in Oncology

    Vom: 1.11.2023